🔓
Sign in as a Member to unlock the full view of TEVA. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
TEVA

Teva Pharmaceutical Industries Limited

Sector: healthcareDrug Manufacturers - Specialty & GenericNYSEMarket Cap: $39.24B

Teva Pharmaceutical Industries Limited is a global generic and specialty pharmaceutical company with significant political exposure through $13.8M in annual doctor payments (2024) but no federal contracts, lobbying, or insider buys.

Next filing → your inbox
Govt Dependence
10/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat TEVA does

Teva develops, manufactures, and markets generic and specialty medicines globally, with revenue lines including generic pharmaceuticals, specialty medicines (CNS, respiratory), and active pharmaceutical ingredients (APIs). The company operates in North America, Europe, and international markets.

12 months past · 3 months futureTEVA activity timeline

$46$35$23 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $44.50 hi $24.21 lo $44.50 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Citadel Advisors · + $144M · 2026-06-30Citadel Advisors · + $115M · 2025-12-31Citadel Advisors · - $97M · 2026-03-31Point72 Asset Management · holds $53M · 2026-06-30Point72 Asset Management · OPENED $48M · 2026-03-31Bridgewater Associates · + $45M · 2026-06-30Bridgewater Associates · + $34M · 2026-03-31Bridgewater Associates · - $24M · 2025-12-31D.E. Shaw & Co. · + $20M · 2025-12-31 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 0 congressional trades shown · 0 insider buys · 9 13F filings · 1 past bill actions · 5 upcoming markups

Lifetime Government AwardsTEVA federal contracts by year

$9M
total awarded · 2026–2026
13
contracts on file
2026
peak year ($9M)
$9M $5M 2026: $9M across 13 contracts (peak year) $9M 2026 13 contracts
Top contracts by award amount
$1.2M Department of Defense 2026-06-16 8512183379!ADENOVIRUS TYPE 4 A
$1.0M Department of Defense 2026-05-11 8512097239!ADENOVIRUS TYPE 4 A
$1.0M Department of Defense 2026-06-16 8512183483!ADENOVIRUS TYPE 4 A
$1.0M Department of Defense 2026-07-14 8512238186!ADENOVIRUS TYPE 4 AND TYPE 7
$687K Department of Defense 2026-05-11 8512097278!ADENOVIRUS TYPE 4 A
1 years · 13 contracts

Smart Money · 13F HoldingsHedge funds holding TEVA

$263.4M
Total TEVA held by tracked 13F funds
7
Funds with TEVA positions
Citadel Advisors $144M +32% 2026-06-30
Point72 Asset Management $53M holds 2026-06-30
Bridgewater Associates $45M +18% 2026-06-30
Two Sigma Investments $9M -26% 2026-06-30
D.E. Shaw & Co. $6M +29% 2026-06-30
AQR Capital Management $4M +43% 2026-06-30
ARK Investment Management $3M holds 2026-09-30

Congressional TradesWho in Congress is trading TEVA

2020-11-13 Greg Gianforte R-Montana · house purchase $15,001 - $50,000
2020-11-13 Greg Gianforte R-Montana · house Purchase $15,001 - $50,000
2020-05-07 Donna Shalala D-Florida · house sale $1,001 - $15,000
2020-05-07 Donna Shalala D-Florida · house Sale $1,001 - $15,000
2019-06-19 David Price D-North Carolina · house sale $1,001 - $15,000
2019-06-19 David Price D-North Carolina · house Sale $1,001 - $15,000
2018-02-12 Thad Cochran R-Mississippi · senate purchase $15,001 - $50,000 49d late
2018-02-12 Thad Cochran R-Mississippi · senate Purchase $15,001 - $50,000 49d late
2017-05-30 Thad Cochran R-Mississippi · senate sale $1,001 - $15,000 48d late
2017-05-30 Thad Cochran R-Mississippi · senate Sale (Full) $1,001 - $15,000 48d late
2017-06-15 Patty Murray D-Washington · senate sale $1,001 - $15,000
2017-06-15 Patty Murray D-Washington · senate Sale (Full) $1,001 - $15,000
30+ trades on file · most recent 2020-12-02

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

11
option exercises · $8.3M
For TEVA, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting TEVALive legislation impacting this stock

Political ProfileWhere TEVA sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) due to healthcare sector and doctor payment exposure ($13.8M in 2024). EVIDENTIARY: No federal contracts, lobbying, insider buys (tier F, 0 buys), or congressional trades. Net: Regulatory overhead without direct political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Increased scrutiny of doctor payments under transparency laws
    HHS/CMS
    "get_political_influence.doctor_payments shows $13.8M in 2024 payments to doctors by Teva Pharmaceuticals USA, Inc."

Regulatory opportunities

  • Potential generic drug legislation easing market entry
    FDA
    "Recent bill_impacts include multiple healthcare bills with low impact_ratios (0.0001-0.0002), indicating minor regulatory sensitivity"
Member intelligence layer

Live signals + predictions for TEVA — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout TEVA & political exposure

Does Teva Pharmaceutical Industries Limited (TEVA) hold federal contracts?
Yes. Teva Pharmaceutical Industries Limited has 13 federal contract awards totaling $9,446,976, primarily from agencies including Department of Defense. See full contract list and amounts on this page.
Has Congress traded TEVA stock?
52 congressional trades by 11 unique members of Congress, most recently on 2020-11-13. See the Congressional Trading panel for politician-by-politician breakdown.
What is TEVA political risk profile?
Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track TEVA political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. TEVA data is updated daily from these official federal sources.